TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Norovent AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
12,538
|
12,704
|
11,491 |
Financial expenses |
8
|
15
|
-1 |
Earnings before taxes |
878
|
813
|
1,071 |
Total assets |
4,852
|
4,396
|
3,839 |
Current assets |
3,192
|
2,663
|
2,460 |
Current liabilities |
1,886
|
2,645
|
2,503 |
Equity capital |
2,075
|
1,562
|
1,270 |
- share capital |
102
![]() |
102
![]() |
102 |
Employees (average) |
10
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
42.8%
|
35.5%
|
33.1% |
Turnover per employee |
1,270
|
958 | |
Profit as a percentage of turnover |
7.0%
|
6.4%
|
9.3% |
Return on assets (ROA) |
18.3%
|
18.8%
|
27.9% |
Current ratio |
169.2%
|
100.7%
|
98.3% |
Return on equity (ROE) |
42.3%
|
52.0%
|
84.3% |
Change turnover |
-166
|
1,213
|
-379 |
Change turnover % |
-1%
|
11%
|
-3% |
Chg. No. of employees |
-2
|
1 | |
Chg. No. of employees % |
-17%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.